Literature DB >> 32999020

Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication.

Matteo Ferrari1, Alessandra Zevini1, Enrico Palermo1, Michela Muscolini1, Magdalini Alexandridi1, Marilena P Etna2, Eliana M Coccia2, Ana Fernandez-Sesma3, Carolyn Coyne4, Donna D Zhang5, Ernesto T A Marques4, David Olagnier6, John Hiscott7.   

Abstract

Dengue virus (DENV) is a mosquito-borne virus that infects upward of 300 million people annually and has the potential to cause fatal hemorrhagic fever and shock. While the parameters contributing to dengue immunopathogenesis remain unclear, the collapse of redox homeostasis and the damage induced by oxidative stress have been correlated with the development of inflammation and progression toward the more severe forms of disease. In the present study, we demonstrate that the accumulation of reactive oxygen species (ROS) late after DENV infection (>24 hpi) resulted from a disruption in the balance between oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent antioxidant response. The DENV NS2B3 protease complex strategically targeted Nrf2 for degradation in a proteolysis-independent manner; NS2B3 licensed Nrf2 for lysosomal degradation. Impairment of the Nrf2 regulator by the NS2B3 complex inhibited the antioxidant gene network and contributed to the progressive increase in ROS levels, along with increased virus replication and inflammatory or apoptotic gene expression. By 24 hpi, when increased levels of ROS and antiviral proteins were observed, it appeared that the proviral effect of ROS overcame the antiviral effects of the interferon (IFN) response. Overall, these studies demonstrate that DENV infection disrupts the regulatory interplay between DENV-induced stress responses, Nrf2 antioxidant signaling, and the host antiviral immune response, thus exacerbating oxidative stress and inflammation in DENV infection.IMPORTANCE Dengue virus (DENV) is a mosquito-borne pathogen that threatens 2.5 billion people in more than 100 countries annually. Dengue infection induces a spectrum of clinical symptoms, ranging from classical dengue fever to severe dengue hemorrhagic fever or dengue shock syndrome; however, the complexities of DENV immunopathogenesis remain controversial. Previous studies have reported the importance of the transcription factor Nrf2 in the control of redox homeostasis and antiviral/inflammatory or death responses to DENV. Importantly, the production of reactive oxygen species and the subsequent stress response have been linked to the development of inflammation and progression toward the more severe forms of the disease. Here, we demonstrate that DENV uses the NS2B3 protease complex to strategically target Nrf2 for degradation, leading to a progressive increase in oxidative stress, inflammation, and cell death in infected cells. This study underlines the pivotal role of the Nrf2 regulatory network in the context of DENV infection.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  DENV; NS2B3; Nrf2; dengue; immunometabolism; inflammation; interferon; oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 32999020      PMCID: PMC7925186          DOI: 10.1128/JVI.01551-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  C11-BODIPY(581/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology.

Authors:  Gregor P C Drummen; Lydia C M van Liebergen; Jos A F Op den Kamp; Jan A Post
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

2.  In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates.

Authors:  Rabuesak Khumthong; Chanan Angsuthanasombat; Sakol Panyim; Gerd Katzenmeier
Journal:  J Biochem Mol Biol       Date:  2002-03-31

3.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

4.  Assessment of biochemical and antioxidative status in patients suffering from dengue fever.

Authors:  Mahmood Rasool; Arif Malik; Khalid Mahmud Khan; Muhammad Saeed Qureshi; Beenish Shabbir; Sara Zahid; Muhammad Asif; Abdul Manan; Sana Rashid; Saima Rubab Khan; Hafiz Muhammad Arsalan; Rabail Alam; Mahwish Arooj; Mahmood Husain Qazi; Adeel Gulzar Ahmed Chaudhary; Adel Mohammed Abuzenadah; Mohammed Hussain Al-Qahtani; Sajjad Karim
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

Review 5.  Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents.

Authors:  Sadagopan Magesh; Yu Chen; Longqin Hu
Journal:  Med Res Rev       Date:  2012-05-01       Impact factor: 12.944

6.  Enterovirus 71 induces integrin β1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication.

Authors:  Wei-Hsuan Tung; Hsi-Lung Hsieh; I-Ta Lee; Chuen-Mao Yang
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

7.  Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction.

Authors:  Krishnakumar Devadas; Subhash Dhawan
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

8.  Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals.

Authors:  T Akaike; Y Noguchi; S Ijiri; K Setoguchi; M Suga; Y M Zheng; B Dietzschold; H Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  DENV inhibits type I IFN production in infected cells by cleaving human STING.

Authors:  Sebastian Aguirre; Ana M Maestre; Sarah Pagni; Jenish R Patel; Timothy Savage; Delia Gutman; Kevin Maringer; Dabeiba Bernal-Rubio; Reed S Shabman; Viviana Simon; Juan R Rodriguez-Madoz; Lubbertus C F Mulder; Glen N Barber; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

10.  Dengue virus targets the adaptor protein MITA to subvert host innate immunity.

Authors:  Chia-Yi Yu; Tsung-Hsien Chang; Jian-Jong Liang; Ruei-Lin Chiang; Yi-Ling Lee; Ching-Len Liao; Yi-Ling Lin
Journal:  PLoS Pathog       Date:  2012-06-28       Impact factor: 6.823

View more
  9 in total

Review 1.  Potential Medicinal Plants for the Treatment of Dengue Fever and Severe Acute Respiratory Syndrome-Coronavirus.

Authors:  Mohammed S M Saleh; Yusof Kamisah
Journal:  Biomolecules       Date:  2020-12-30

Review 2.  Life as a Vector of Dengue Virus: The Antioxidant Strategy of Mosquito Cells to Survive Viral Infection.

Authors:  Chih-Chieh Cheng; Eny Sofiyatun; Wei-June Chen; Lian-Chen Wang
Journal:  Antioxidants (Basel)       Date:  2021-03-05

3.  Influenza Virus Down-Modulates G6PD Expression and Activity to Induce Oxidative Stress and Promote Its Replication.

Authors:  Marta De Angelis; Donatella Amatore; Paola Checconi; Alessandra Zevini; Alessandra Fraternale; Mauro Magnani; John Hiscott; Giovanna De Chiara; Anna Teresa Palamara; Lucia Nencioni
Journal:  Front Cell Infect Microbiol       Date:  2022-01-06       Impact factor: 5.293

Review 4.  Mitochondria as a Cellular Hub in Infection and Inflammation.

Authors:  Pauline Andrieux; Christophe Chevillard; Edecio Cunha-Neto; João Paulo Silva Nunes
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

5.  Infection of Endothelial Cells by Dengue Virus Induces ROS Production by Different Sources Affecting Virus Replication, Cellular Activation, Death and Vascular Permeability.

Authors:  Lana Monteiro Meuren; Elisa Beatriz Prestes; Michelle Premazzi Papa; Luiza Rachel Pinheiro de Carvalho; Yasmin Mucunã Mustafá; Leandro Silva da Costa; Andrea T Da Poian; Marcelo Torres Bozza; Luciana Barros Arruda
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

6.  Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense.

Authors:  Yan Wang; Guanqin Ma; Xue-Feng Wang; Lei Na; Xing Guo; Jiaqi Zhang; Cong Liu; Cheng Du; Ting Qi; Yuezhi Lin; Xiaojun Wang
Journal:  PLoS Pathog       Date:  2022-02-09       Impact factor: 6.823

7.  Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I-Mediated Antiviral Responses in Primary Human Dendritic Cells.

Authors:  Alessandra Zevini; Enrico Palermo; Daniele Di Carlo; Magdalini Alexandridi; Serena Rinaldo; Alessio Paone; Francesca Cutruzzola; Marilena P Etna; Eliana M Coccia; David Olagnier; John Hiscott
Journal:  Front Cell Infect Microbiol       Date:  2022-07-18       Impact factor: 6.073

8.  Upregulation of nuclear factor E2-related factor 2 (Nrf2) represses the replication of herpes simplex virus type 1.

Authors:  Li Zhang; Jiao Wang; Zhan Wang; Ying Li; Hui Wang; Hongtu Liu
Journal:  Virol J       Date:  2022-01-31       Impact factor: 4.099

9.  Dengue Virus Replication Is Associated with Catecholamine Biosynthesis and Metabolism in Hepatocytes.

Authors:  George Mpekoulis; Vassilina Tsopela; Anna Chalari; Katerina I Kalliampakou; Georgios Panos; Efseveia Frakolaki; Raphaela S Milona; Diamantis C Sideris; Dido Vassilacopoulou; Niki Vassilaki
Journal:  Viruses       Date:  2022-03-09       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.